e-Journal of Age Management Medicine: Current Issue

Ejournal of Age Management
Ejournal of Age Management Medicine
Ejournal November 2018
Featured Articles

How to Effectively Use Genomics in a Clinical Age Management Practice

Jeff Morris


In a workshop at the October AMMG conference, participants will learn how to make genomics clinically actionable so that better brain, cardiac and overall health and longevity can be obtained for patients.
Read Full Article

How CBD Could Help Combat Age-Related Macular Degeneration (AMD)

Crystal Wilson

Age-Related Macular Degeneration (AMD) has potential to be slowed down by CBD, a substance produced from the cannabis plant. Its anti-inflammatory activities might lessen macula inflammation, its neuroprotective benefits might shield retinal cells, and its antioxidant characteristics may decrease the progression of AMD.
Read Full Article

Borrelia Burgdorferi, a Root Cause of Inflammatory Bowel Disease: A Case Re-port of Successful Treatment and Remission

Elliot Dinetz, M.D., Yusuf Saleeby, M.D.

The Borrelia species is recognized to cause a myriad of non-specific symptoms among Lyme patients. It has also been documented in the literature to have the ability to incite autoimmune responses. This underlying cause may help many patients obtain the proper diagnosis so that curative treatment may be received.
Read Full Article

Latest AMM News

FDA Fully Approves ‘Novel’ Alzheimer’s Disease Drug Legembi, Will Be Covered by Medicare

Will Unpredictable Side Effects Dim the Promise of New Alzheimer’s Drugs?

Quest Diagnostics Launches Alzheimer’s Blood Test for Consumers


Drug to Turbocharge the Brain in Old Age Has Come a Step Closer

Daily Use of Low-Dose Aspirin May Increase Anemia Risk in Healthy Older Adults: Study

read more read more read more read more read more
Womens Health

Cardiovascular Safety of Testosterone Replacement Therapy
A. Michael Lincoff, M.D., et al

The cardiovascular safety of testosterone-replacement therapy in middle-aged and older men with hypogonadism has not been determined. A trial of 5246 men 45 to 80 years of age found in men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events.
Read Full Article

Disorcerds of Aging

‘It’s Big-Time Progress’: Groundbreaking Alzheimer’s Drug Soon to Gain FDA Approval
Ann Marie Barron

A groundbreaking new Alzheimer's drug that slows the progression of the devastating disease is expected to be approved by the Food and Drug Administration (FDA).
Read Full Article

Disorcerds of Aging

Blood Test for 50 Types of Cancer Could Speed Up Diagnosis, Study Suggests
Andrew Gregory

A blood test for more than 50 forms of cancer could help speed up diagnosis and fast-track patients for treatment, a study suggests. NHS trial results of the liquid biopsy suggest the Galleri blood test has the potential to spot and rule out cancer in people with symptoms.
Read Full Article

Brain Health

Want to Live Longer? This Common Supplement Might Be An Anti-Aging Key
Miriam Fauzia

A published study found that taurine appears to decline as an organism ages, and that supplementing taurine back into a worm, mouse, or monkey’s diet appears to extend the lifespan of these animals along with reversing age-related damage in tissues like the muscle, bone, and brain.
Read Full Article

Psychological Health

Cannabis Use Linked to Epigenetic Changes, Scientists Discover
Rebecca Dyer

Using cannabis may cause changes in the human body's epigenome, a study of over 1,000 adults suggests. Studies examining the effect of marijuana on age-related health outcomes may provide further insight into the long-term effect of marijuana on health.
Read Full Article

Contact Ewells@agemed.org

AMMG small logo This e-Journal is the Official Publication of the Age Management Medicine Group (AMMG), and is provided to industry colleagues and friends free of charge. The E-Journal of Age Management Medicine, Greg Fillmore & Rick Merner, Co-Publishers.

The Age Management Medicine Group (AMMG) is a division of Red River Solutions, Inc. with a goal of providing education and information on the sub-specialty of Age Management Medicine to physicians and healthcare professionals through evidence based continuing medical education conferences, workshops, seminars and publications. Age Management Medicine is a proactive, preventative approach focused on preservation of optimum human function and quality of life making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.

Any comments, concerns or interest in publishing articles or advertising in this newsletter should be directed to Journal@AgeMed.org.


1534 Serrano Circle
Naples, FL 34105
phone: (239) 330-7495
e-mail: Journal@AgeMed.org

Copyright 2023 AMMG. All rights reserved. This publication is protected by United States copyright and other intellectual property laws and may not be reproduced, rewritten, distributed, re-disseminated, transmitted, displayed, published or broadcast, directly or indirectly, in any medium without the prior written permission of AMMG.

The Age Management Medicine Group (AMMG) provides evidence-based continuing medical education conferences, publications, web media and membership for healthcare professionals.

Gold Sponsor Gold Sponsor


Hue Light USA_ammg

Fortune Law Firm_ammg

Silver Sponsors

Cenegenics Sponsors AMMG

Cleerly Medical Sponsors AMMG





University Compounding Pharmacy sponsors ammg

Zero Gravity sponsors ammg

see all sponsors

Agemed Footer Art